中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 6
Jun.  2024
Turn off MathJax
Article Contents

Pathological diagnosis of autoimmune hepatitis

DOI: 10.12449/JCH240603
More Information
  • Corresponding author: YANG Wenjun, yangwenjun3463@163.com (ORCID: 0000-0003-2021-595X)
  • Received Date: 2024-03-30
  • Accepted Date: 2024-05-15
  • Published Date: 2024-06-25
  • Autoimmune hepatitis (AIH) is an immune-mediated inflammatory disease of the liver parenchyma, which is characterized by hypergammaglobulinemia, the presence of autoantibodies, and typical abnormalities in liver histology; however, the diverse clinical manifestations of AIH and the lack of specific serological markers have brought difficulties and challenges in the diagnosis of AIH. Although portal lymphoplasmacytic infiltration, interface hepatitis, lymphocyte emperipolesis, and hepatocyte rosettes are the typical histological features of AIH, many other histological features can also be observed in AIH, including centrilobular necrosis and Kupffer cell hyaline globules. Therefore, no single histological feature can be used for the diagnosis of AIH, and a confirmed diagnosis should be made with reference to clinical and laboratory examinations, with the exclusion of liver diseases due to other causes. This article summarizes the histological features of AIH, different histopathological spectrum, common clinical issues, differential diagnosis, and recent advances.

     

  • loading
  • [1]
    ZHANG XC, JAIN D. The many faces and pathologic diagnostic challenges of autoimmune hepatitis[J]. Hum Pathol, 2023, 132: 114- 125. DOI: 10.1016/j.humpath.2022.06.019.
    [2]
    MANNS MP, CZAJA AJ, GORHAM JD, et al. Diagnosis and management of autoimmune hepatitis[J]. Hepatology, 2010, 51( 6): 2193- 2213. DOI: 10.1002/hep.23584.
    [3]
    MACK CL, ADAMS D, ASSIS DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases[J]. Hepatology, 2020, 72( 2): 671- 722. DOI: 10.1002/hep.31065.
    [4]
    SCIVERES M, NASTASIO S, MAGGIORE G. Novel diagnostic and therapeutic strategies in juvenile autoimmune hepatitis[J]. Front Pediatr, 2019, 7: 382. DOI: 10.3389/fped.2019.00382.
    [5]
    NASTASIO S, MOSCA A, ALTERIO T, et al. Juvenile autoimmune hepatitis: Recent advances in diagnosis, management and long-term outcome[J]. Diagnostics, 2023, 13( 17): 2753. DOI: 10.3390/diagnostics13172753.
    [6]
    GURUNG A, ASSIS DN, MCCARTY TR, et al. Histologic features of autoimmune hepatitis: A critical appraisal[J]. Hum Pathol, 2018, 82: 51- 60. DOI: 10.1016/j.humpath.2018.07.014.
    [7]
    FRANCESCHINI T, VASURI F, MURATORI P, et al. A practical histological approach to the diagnosis of autoimmune hepatitis: experience of an Italian tertiary referral center[J]. Virchows Arch, 2021, 479( 5): 937- 945. DOI: 10.1007/s00428-021-03122-5.
    [8]
    ZHAO SX, LI WC, FU N, et al. Emperipolesis mediated by CD8+ T cells correlates with biliary epithelia cell injury in primary biliary cholangitis[J]. J Cell Mol Med, 2020, 24( 2): 1268- 1275. DOI: 10.1111/jcmm.14752.
    [9]
    LOHSE AW, SEBODE M, BHATHAL PS, et al. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology[J]. Liver Int, 2022, 42( 5): 1058- 1069. DOI: 10.1111/liv.15217.
    [10]
    AIZAWA Y, ABE H, SUGITA T, et al. Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis[J]. Eur J Gastroenterol Hepatol, 2016, 28( 4): 391- 397. DOI: 10.1097/MEG.0000000000000545.
    [11]
    UEDA K, AIZAWA Y, KINOSHITA C, et al. Centrilobular zonal necrosis is a unique subtype of autoimmune hepatitis: A cohort study[J]. Medicine, 2022, 101( 29): e29484. DOI: 10.1097/MD.0000000000029484.
    [12]
    CANH HN, HARADA K, OUCHI H, et al. Acute presentation of autoimmune hepatitis: A multicentre study with detailed histological evaluation in a large cohort of patients[J]. J Clin Pathol, 2017, 70( 11): 961- 969. DOI: 10.1136/jclinpath-2016-204271.
    [13]
    BIHARI C, RASTOGI A, SARIN SK. Postinfantile giant cell hepatitis: An etiological and prognostic perspective[J]. Hepat Res Treat, 2013, 2013: 601290. DOI: 10.1155/2013/601290.
    [14]
    KHEDR MA, ADAWY NM, SALIM TA, et al. Kupffer cell hyaline globules in children with autoimmune hepatitis[J]. J Clin Exp Hepatol, 2022, 12( 1): 20- 28. DOI: 10.1016/j.jceh.2021.04.013.
    [15]
    CZAJA AJ, CARPENTER HA. Autoimmune hepatitis with incidental histologic features of bile duct injury[J]. Hepatology, 2001, 34( 4 Pt 1): 659- 665. DOI: 10.1053/jhep.2001.27562.
    [16]
    MEHENDIRATTA V, MITROO P, BOMBONATI A, et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis[J]. Clin Gastroenterol Hepatol, 2009, 7( 1): 98- 103. DOI: 10.1016/j.cgh.2008.08.043.
    [17]
    KHEDR MA, SALEM TA, BOGHDADI GM, et al. Seronegative autoimmune hepatitis in children: A real diagnostic challenge[J]. Wien Klin Wochenschr, 2022, 134( 5-6): 195- 201. DOI: 10.1007/s00508-021-01907-x.
    [18]
    HARTL J, MIQUEL R, ZACHOU K, et al. Features and outcome of AIH patients without elevation of IgG[J]. JHEP Rep, 2020, 2( 3): 100094. DOI: 10.1016/j.jhepr.2020.100094.
    [19]
    MONTANO-LOZA AJ, CARPENTER HA, CZAJA AJ. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis[J]. J Clin Gastroenterol, 2008, 42( 9): 1047- 1053. DOI: 10.1097/MCG.0b013e3181587d18.
    [20]
    de ROZA MA, LAMBA M, GOH GBB, et al. Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study[J]. World J Gastroenterol, 2021, 27( 43): 7563- 7571. DOI: 10.3748/wjg.v27.i43.7563.
    [21]
    SUN SM, WANG YY, ZHANG Q, et al. Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease[J]. J Dig Dis, 2018, 19( 8): 498- 507. DOI: 10.1111/1751-2980.12646.
    [22]
    TAKAHASHI A, ARINAGA-HINO T, OHIRA H, et al. Nonalcoholic fatty liver disease in patients with autoimmune hepatitis[J]. JGH Open, 2018, 2( 2): 54- 58. DOI: 10.1002/jgh3.12046.
    [23]
    JOHNSON PJ, MCFARLANE IG. Meeting report: International autoimmune hepatitis group[J]. Hepatology, 1993, 18( 4): 998- 1005. DOI: 10.1002/hep.1840180435.
    [24]
    ALVAREZ F, BERG PA, BIANCHI FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999, 31( 5): 929- 938. DOI: 10.1016/s0168-8278(99)80297-9.
    [25]
    HENNES EM, ZENIYA M, CZAJA AJ, et al. Simplified criteria for the diagnosis of autoimmune Hepatitis[J]. Hepatology, 2008, 48: 169- 176. DOI: 10.1002/hep.22322.
    [26]
    KABAÇAM G, WAHLIN S, EFE C. Autoimmune hepatitis triggered by COVID-19: A report of two cases[J]. Liver Int, 2021, 41( 10): 2527- 2528. DOI: 10.1111/liv.15044.
    [27]
    ŞENER AG, AYDıN N, CEYLAN C, et al. Investigation of antinuclear antibodies in chronic hepatitis B patients[J]. Mikrobiyol Bul, 2018, 52( 4): 425- 430. DOI: 10.5578/mb.67262.
    [28]
    ZHANG XC, OUYANG J, THUNG SN. Histopathologic manifestations of drug-induced hepatotoxicity[J]. Clin Liver Dis, 2013, 17( 4): 547- 564, vii-viii. DOI: 10.1016/j.cld.2013.07.004.
    [29]
    PATIL PA, ZHANG XC. Pathologic manifestations of gastrointestinal and hepatobiliary injury in immune checkpoint inhibitor therapy[J]. Arch Pathol Lab Med, 2021, 145( 5): 571- 582. DOI: 10.5858/arpa.2020-0070-RA.
    [30]
    SUZUKI A, BRUNT EM, KLEINER DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury[J]. Hepatology, 2011, 54( 3): 931- 939. DOI: 10.1002/hep.24481.
    [31]
    HONG-CURTIS J, YEH MMC, JAIN D, et al. Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis[J]. J Clin Gastroenterol, 2004, 38( 10): 906- 909. DOI: 10.1097/00004836-200411000-00015.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(1)

    Article Metrics

    Article views (340) PDF downloads(86) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return